Get the Stockscreener App
336.82
0.44%
0.11
Natera Inc stock is traded at $336.82, with a volume of 866.48K.
It is up +0.44% in the last 24 hours and up +29.09% over the past month.
Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.
See More
Previous Close:
$336.71
Open:
$333.29
24h Volume:
866.48K
Relative Volume:
0.60
Market Cap:
$48.58B
Revenue:
$2.50B
Net Income/Loss:
$-226.32M
P/E Ratio:
-205.23
EPS:
-1.6412
Net Cash Flow:
$71.51M
1W Performance:
+4.04%
1M Performance:
+29.09%
6M Performance:
+56.50%
1Y Performance:
+104.09%
1-Day Range:
$333.29
$340.96
1-Week Range:
$320.00
$340.96
52-Week Range:
$157.43
$340.96
Natera Inc Stock (NTRA) Company Profile
Name
Natera Inc
Sector
Industry
Phone
650-249-9090
Address
13011 MCCALLEN PASS, AUSTIN, CA
Compare NTRA vs TMO, DHR, IDXX, A
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NTRA
Natera Inc
|
337.04 | 46.82B | 2.50B | -226.32M | 71.51M | -1.6412 |
TMO
Thermo Fisher Scientific Inc
|
634.70 | 232.03B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
215.67 | 151.78B | 24.78B | 3.68B | 5.29B | 5.1743 |
IDXX
Idexx Laboratories Inc
|
554.04 | 43.00B | 4.45B | 1.10B | 1.06B | 13.59 |
A
Agilent Technologies Inc
|
154.03 | 44.14B | 7.23B | 1.41B | 1.09B | 4.979 |
Natera Inc Stock (NTRA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-14-26 | Initiated | William Blair | Outperform |
| Jan-07-26 | Initiated | Citigroup | Buy |
| Dec-02-25 | Resumed | Morgan Stanley | Overweight |
| Oct-27-25 | Upgrade | BNP Paribas Exane | Underperform → Neutral |
| Sep-22-25 | Resumed | Wells Fargo | Equal Weight |
| Mar-13-25 | Initiated | RBC Capital Mkts | Outperform |
| Jan-23-25 | Initiated | Barclays | Overweight |
| Jun-03-24 | Resumed | Jefferies | Buy |
| Apr-08-24 | Resumed | Craig Hallum | Buy |
| Feb-20-24 | Downgrade | Raymond James | Strong Buy → Outperform |
| Dec-29-23 | Reiterated | BTIG Research | Buy |
| Dec-14-23 | Initiated | Guggenheim | Buy |
| Dec-13-23 | Initiated | Wolfe Research | Outperform |
| Nov-13-23 | Upgrade | Raymond James | Outperform → Strong Buy |
| Sep-28-23 | Initiated | Bernstein | Mkt Perform |
| Jul-05-23 | Resumed | JP Morgan | Overweight |
| May-05-23 | Initiated | UBS | Buy |
| Jan-18-23 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Aug-25-22 | Initiated | Credit Suisse | Outperform |
| Apr-25-22 | Initiated | Stephens | Overweight |
| Mar-08-22 | Initiated | Goldman | Buy |
| Jan-06-22 | Resumed | Piper Sandler | Overweight |
| Oct-15-21 | Resumed | Cowen | Outperform |
| Jun-15-21 | Initiated | Raymond James | Mkt Perform |
| May-25-21 | Initiated | Wells Fargo | Overweight |
| Jan-28-21 | Initiated | Truist | Buy |
| Oct-08-20 | Initiated | BTIG Research | Buy |
| Sep-28-20 | Initiated | Morgan Stanley | Overweight |
| Sep-17-20 | Initiated | SVB Leerink | Outperform |
| Jun-10-20 | Resumed | Piper Sandler | Overweight |
| May-07-20 | Upgrade | JP Morgan | Neutral → Overweight |
| Oct-05-18 | Initiated | JP Morgan | Neutral |
| Jul-05-18 | Reiterated | Piper Jaffray | Overweight |
| Aug-07-17 | Reiterated | Morgan Stanley | Overweight |
| Nov-10-16 | Reiterated | The Benchmark Company | Buy |
| May-23-16 | Reiterated | The Benchmark Company | Buy |
| May-11-16 | Reiterated | The Benchmark Company | Buy |
| Apr-19-16 | Initiated | The Benchmark Company | Buy |
| Sep-28-15 | Upgrade | Wedbush | Neutral → Outperform |
| Aug-14-15 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Aug-04-15 | Initiated | Robert W. Baird | Outperform |
| Jul-27-15 | Initiated | Morgan Stanley | Equal-Weight |
| Jul-27-15 | Initiated | Piper Jaffray | Overweight |
| Jul-27-15 | Initiated | Wedbush | Neutral |
View All
Natera Inc Stock (NTRA) Latest News
Natera’s Oncology Push Has Wall Street Paying Up - Finimize
Natera Inc. Earnings Call Highlights Rapid Growth - TipRanks
Natera raises FY26 guidance to $2.85B-$2.91B after record Q2 volume - scanx.trade
Silvant Capital Management LLC Takes $12.32 Million Position in Natera, Inc. $NTRA - MarketBeat
Virtus Advisers LLC Takes $1.01 Million Position in Natera, Inc. $NTRA - MarketBeat
Ninepoint Partners LP Purchases New Position in Natera, Inc. $NTRA - MarketBeat
D L Carlson Investment Group Inc. Makes New $3.49 Million Investment in Natera, Inc. $NTRA - MarketBeat
Deutsche Bank AG Purchases Shares of 320,037 Natera, Inc. $NTRA - MarketBeat
Danske Bank A S Makes New Investment in Natera, Inc. $NTRA - MarketBeat
Natera, Inc. (NASDAQ:NTRA) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
Natera (NTRA) Earnings Snapshot: Profit Per Share Surpasses Its Benchmark; Price Reaction: The Stock Loses 0.07% at the CloseEPS Guidance Update - vinanet.vn
Billionaire Stanley Druckenmiller's Top Holding Is Up 37% This Year. Is the Market Pricing in the Full Story? - AOL.com
Natera stock reaches all-time high at 326.26 USD By Investing.com - Investing.com Australia
Natera (NASDAQ:NTRA) Reaches New 1-Year HighTime to Buy? - MarketBeat
Natera stock reaches all-time high at 326.26 USD - Investing.com
Natera (NTRA) Q2 2026 Results: The Bottom-Line Figure Outpaces Its Comparison at the Close; Latest Reaction - vinanet.vn
Mitsubishi UFJ Asset Management Co. Ltd. Takes $50.42 Million Position in Natera, Inc. $NTRA - MarketBeat
Edmond DE Rothschild Holding S.A. Takes Position in Natera, Inc. $NTRA - MarketBeat
Eagle Health Investments LP Makes New Investment in Natera, Inc. $NTRA - MarketBeat
Natera: Even 30% Annual Growth Through 2030 Doesn't Support $310 Per Share (NASDAQ:NTRA) - Seeking Alpha
Natera (NTRA) Quarterly Results: Profit Per Share Surpasses Its Benchmark on the Day - vinanet.vn
Is Natera Inc (NTRA) Overvalued After 4.3% Rally? GF Value Says - GuruFocus
BlackRock Inc. Buys Shares of 10,914,608 Natera, Inc. $NTRA - MarketBeat
Here's How Much $1000 Invested In Natera 10 Years Ago Would Be Worth Today - Benzinga
Q2 Rundown: Natera (NASDAQ:NTRA) Vs Other Biotechnology Stocks - Yahoo Finance
Meeder Asset Management Inc. Takes Position in Natera, Inc. $NTRA - MarketBeat
Pallas Capital Advisors LLC Buys Shares of 9,853 Natera, Inc. $NTRA - MarketBeat
How Investors May Respond To Natera (NTRA) Deepening Its MRD Role In Immunotherapy And Cancer Care - simplywall.st
K.J. Harrison & Partners Inc Buys Shares of 18,850 Natera, Inc. $NTRA - MarketBeat
Natera Inc. (NTRA) Holds Near $313 as Resistance Test LoomsMarket Neutral Pair - Vinanet
Jefferies Maintains Natera(NTRA.US) With Buy Rating, Raises Target Price to $330 - Moomoo
Natera Supports Kupando Trial to Advance ctDNA Monitoring in Cancer - Yahoo Finance
NTRA Looks 42.4% Overvalued on GF Value™ - GuruFocus
Weekly Recap: FIND-CRC progress and analyst price target increases - TradingView
Natera, Inc. (NTRA) Stock Analysis: Navigating the Diagnostics Leader’s 6.68% Potential Upside - DirectorsTalk Interviews
Abbot Financial Management Inc. Takes Position in Natera, Inc. $NTRA - MarketBeat
Empowered Funds LLC Sells 9,708 Shares of Natera, Inc. $NTRA - MarketBeat
Natera director Jonathan Sheena sells $2.89m in stock By Investing.com - Investing.com Canada
Natera executive chairman Matthew Rabinowitz sells $641,800 stock By Investing.com - Investing.com Australia
Natera executive chairman Matthew Rabinowitz sells $641,800 stock - Investing.com
Net debt of Natera, Inc. – HAM:45E - TradingView
Natera director Jonathan Sheena sells $2.89m in stock - Investing.com
Natera (NTRA) Stock May Be 49% Undervalued As Guidance Rises - Yahoo Finance
Leeward Financial Partners LLC Invests $5.31 Million in Natera, Inc. $NTRA - MarketBeat
Natera (NTRA) Lands Kupando Trial Deal, Is The Upside Already Priced In? - simplywall.st
GSA Capital Partners LLP Invests $3.08 Million in Natera, Inc. $NTRA - MarketBeat
7,701 Shares in Natera, Inc. $NTRA Bought by Focus Partners Advisor Solutions LLC - MarketBeat
Natera (NTRA) Lands New Trial Collaboration But Is The Valuation Already Priced In - Yahoo Finance
Natera co-founder, Director Sheena Jonathan sells 6,000 shares worth $1.95 million - Bitget
Natera Spotlights Record Signatera Volumes, Raises Outlook at Canaccord Conference - MarketBeat
NTRA Q2 2026 Earnings: Narrower Loss Beats Estimates Despite Soft Share ReactionGeographic Revenue Trends - vinanet.vn
Natera Inc Stock (NTRA) Financials Data
Revenue
Net Income
Cash Flow
EPS
Natera Inc Stock (NTRA) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Rabinowitz Matthew | EXECUTIVE CHAIRMAN |
Aug 07 '26 |
Sale |
320.90 |
2,000 |
641,800 |
2,000 |
| Sheena Jonathan | CO-FOUNDER |
Aug 07 '26 |
Sale |
315.66 |
9,150 |
2,888,325 |
236,464 |
0.97%
0.81%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):